Substance active (DCI)
- guanfacine (chlorhydrate)
Informations techniques
Exploitant
Laboratoire NOVARTIS PHARMA
Présentation
ESTULIC 2 mg, comprimé
B/30 : CIP 323 305-8
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
BYCVCyETu0h9S6vY